Evan/ Fa Jones - 05 Nov 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Nov 2025, 16:10:25 UTC
Prior SEC filing
23 Jun 2025
Next SEC filing
26 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Wygant, as attorney-in-fact

Key filing fact

Evan/ Fa Jones filed Form 4 for VERACYTE, INC. (VCYT) on 07 Nov 2025.

Key facts

  • This page summarizes Evan/ Fa Jones's Form 4 filing for VERACYTE, INC. (VCYT).
  • 12 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 07 Nov 2025, 16:10.

Change

  • Previous filing in this sequence was filed on 23 Jun 2025.
  • Current net transaction value: -$1,738,088.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001020741 Primary reporting owner

JONES EVAN/ FA

Relationship
Director
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Signature date
07 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Options Exercise

Transaction value
$52,800
Shares
+10,000
Change %
+23%
Price
$5.28
Shares after
53,664
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1
VCYT transaction

Common Stock

Options Exercise

Transaction value
$79,400
Shares
+10,000
Change %
+19%
Price
$7.94
Shares after
63,664
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1
VCYT transaction

Common Stock

Options Exercise

Transaction value
$76,000
Shares
+10,000
Change %
+16%
Price
$7.60
Shares after
73,664
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1
VCYT transaction

Common Stock

Sale

Transaction value
$17,031
Shares
-408
Change %
-0.55%
Price
$41.74
Shares after
73,256
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F2
VCYT transaction

Common Stock

Sale

Transaction value
$48,455
Shares
-1,126
Change %
-1.5%
Price
$43.03
Shares after
72,130
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F3
VCYT transaction

Common Stock

Sale

Transaction value
$474,702
Shares
-10,837
Change %
-15%
Price
$43.80
Shares after
61,293
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F4
VCYT transaction

Common Stock

Sale

Transaction value
$264,640
Shares
-5,872
Change %
-9.6%
Price
$45.07
Shares after
55,421
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F5
VCYT transaction

Common Stock

Sale

Transaction value
$1,110,990
Shares
-24,296
Change %
-44%
Price
$45.73
Shares after
31,125
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F6
VCYT transaction

Common Stock

Sale

Transaction value
$30,469
Shares
-657
Change %
-2.1%
Price
$46.38
Shares after
30,468
Date
05 Nov 2025
Ownership
Direct
Footnotes
F1, F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-10,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$5.28
Footnotes
F1, F8
VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-10,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$7.94
Footnotes
F1, F8
VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-10,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$7.60
Footnotes
F1, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

Footnote F2

Represents weighted average sales price. Sale prices for the transactions range from $41.10 to $41.97. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F3

Represents weighted average sales price. Sale prices for the transactions range from $42.285 to $43.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F4

Represents weighted average sales price. Sale prices for the transactions range from $43.29 to $44.29. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F5

Represents weighted average sales price. Sale prices for the transactions range from $44.335 to $45.335. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F6

Represents weighted average sales price. Sale prices for the transactions range from $45.34 to $44.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F7

Represents weighted average sales price. Sale prices for the transactions range from $46.35 to $46.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Footnote F8

The option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .